IMA Karnataka welcomes you to a live webinar on, “Real-world evidence of Remdesivir & anti-viral therapy”
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) replication leads to many of the clinical manifestations of COVID-19, antiviral therapies are being investigated for the treatment of COVID-19.
In this session, Dr. Vishnu Sharma will share his knowledge and experience in treating COVID patients with “Anti-viral therapies.” .The session will then be continued by Dr. Ravindra Mehta renowned pulmonologist, he will share his insights on “Real-world evidence of Remdesivir”
We wish you a great learning experience.
Event Sponsored by Mylan Pharmaceuticals Private Limited, a Viatris Company.
Date: 08 May 21
Time: 06:30-08:00 Pm
What will be covered:
Introduction and Poll Welcome note: Dr. M. Venkatachalapathy, President - IMA Karnataka. Session 1- “Anti-viral therapies in COVID”: Dr Vishnu Sharma. MD, DNB Professor and Head Department of Respiratory Medicine, A J Institute of Medical Sciences and Research Centre, Kuntikana, Mangalore. Session 2- “Real-world evidence of Remdesivir”: Dr. Ravindra Mehta, Chief of Critical Care, Consultant Pulmonologist/Sleep Medicine Specialist, Apollo Hospitals, Bangalore. Question and Answers. Vote of Thanks: Dr. S. M. Prasad, Secretary - IMA Karnataka.